Hydrophobicity Assessment for AOD-9604

Most wasted peptide budget is decided at the sequence stage, long before the lab gets involved. EndoPhase gives you a hydrophobicity read that ties directly to solubility and handling, for AOD-9604 and any sequence you are weighing up.

Run AOD-9604 preflight

Most wasted peptide budget is decided at the sequence stage, long before the lab gets involved. For a candidate like AOD-9604, the questions worth answering early are practical: is the sequence clean to make, is it stable, and does the intended route even make sense. hydrophobicity assessment is the part of that picture EndoPhase focuses on here.

What hydrophobicity assessment looks at

For AOD-9604, EndoPhase surfaces a hydrophobicity read that ties directly to solubility and handling, in plain language, with the reasoning kept beside the result so a reviewer can agree or push back.

Flagged risks specific to the AOD-9604 sequence, ranked by how much they matter.
A short rationale you can paste into a decision log or share with a reviewer.
A clean handoff to synthesis, with the assumptions written down.

Why do this before synthesis

The cheapest time to catch a problem with a peptide is while it is still just text on a screen. The whole idea is to spend judgement before spending budget. Score it, document the reasoning, and keep the evidence attached for next time.

Request beta access

AOD-9604 Preflight Scoring AOD-9604 Solubility Analysis AOD-9604 Aggregation Risk AOD-9604 Synthesis Difficulty AOD-9604 Net Charge Profile AOD-9604 Oral Delivery Outlook

EndoPhase is research-use software. It does not sell peptides, give medical advice, diagnose, treat, or make claims about the safety or efficacy of any compound named here. Names are used as analysis subjects only.